Bio equivalence and Bio availability Studies in Modern Drug Development

Explores updated BE/BA methodologies, regulatory expectations, pharmacokinetic modeling, and clinical endpoints ensuring safety, efficacy, and interchangeability of generic medicines. It provides insights into advanced study designs and statistical approaches used in drug evaluation. The track also focuses on improving accuracy in assessing drug performance in human systems.

    Related Conference of Bio equivalence and Bio availability Studies in Modern Drug Development

    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Bio equivalence and Bio availability Studies in Modern Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in